BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21870263)

  • 1. Purification of human PARP-1 and PARP-1 domains from Escherichia coli for structural and biochemical analysis.
    Langelier MF; Planck JL; Servent KM; Pascal JM
    Methods Mol Biol; 2011; 780():209-26. PubMed ID: 21870263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of DNA Damage-Dependent PARPs from E. coli for Structural and Biochemical Analysis.
    Langelier MF; Steffen JD; Riccio AA; McCauley M; Pascal JM
    Methods Mol Biol; 2017; 1608():431-444. PubMed ID: 28695525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nondenaturing purification scheme for the DNA-binding domain of poly(ADP-ribose) polymerase, a structure-specific DNA-binding protein.
    Ruscetti T; Newman J; Peat TS; Francis J; Nolan R; Terwilliger TC; Peterson SR; Lehnert BE
    Protein Expr Purif; 1998 Oct; 14(1):79-86. PubMed ID: 9758754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs.
    Gagné JP; Ethier C; Defoy D; Bourassa S; Langelier MF; Riccio AA; Pascal JM; Moon KM; Foster LJ; Ning Z; Figeys D; Droit A; Poirier GG
    DNA Repair (Amst); 2015 Jun; 30():68-79. PubMed ID: 25800440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of Recombinant Human PARP-3.
    Amé JC; Camuzeaux B; Dantzer F; Schreiber V
    Methods Mol Biol; 2017; 1608():373-394. PubMed ID: 28695522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications.
    Tao Z; Gao P; Liu HW
    J Am Chem Soc; 2009 Oct; 131(40):14258-60. PubMed ID: 19764761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production, extraction, and purification of human poly(ADP-ribose) polymerase-1 (PARP-1) with high specific activity.
    Knight MI; Chambers PJ
    Protein Expr Purif; 2001 Dec; 23(3):453-8. PubMed ID: 11722183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and biophysical studies of human PARP-1 in complex with damaged DNA.
    Lilyestrom W; van der Woerd MJ; Clark N; Luger K
    J Mol Biol; 2010 Feb; 395(5):983-94. PubMed ID: 19962992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of recombinant poly(ADP-ribose) polymerases.
    Amé JC; Kalisch T; Dantzer F; Schreiber V
    Methods Mol Biol; 2011; 780():135-52. PubMed ID: 21870259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic investigation of phosphorylation sites in poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase.
    Gagné JP; Moreel X; Gagné P; Labelle Y; Droit A; Chevalier-Paré M; Bourassa S; McDonald D; Hendzel MJ; Prigent C; Poirier GG
    J Proteome Res; 2009 Feb; 8(2):1014-29. PubMed ID: 19105632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage.
    Riccio AA; Cingolani G; Pascal JM
    Nucleic Acids Res; 2016 Feb; 44(4):1691-702. PubMed ID: 26704974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain.
    Dawicki-McKenna JM; Langelier MF; DeNizio JE; Riccio AA; Cao CD; Karch KR; McCauley M; Steffen JD; Black BE; Pascal JM
    Mol Cell; 2015 Dec; 60(5):755-768. PubMed ID: 26626480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase-1 could facilitate the religation of topoisomerase I-linked DNA inhibited by camptothecin.
    Park SY; Cheng YC
    Cancer Res; 2005 May; 65(9):3894-902. PubMed ID: 15867389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
    Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
    FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the catalytic domain of human PARP2 in complex with PARP inhibitor ABT-888.
    Karlberg T; Hammarström M; Schütz P; Svensson L; Schüler H
    Biochemistry; 2010 Feb; 49(6):1056-8. PubMed ID: 20092359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1.
    Eustermann S; Wu WF; Langelier MF; Yang JC; Easton LE; Riccio AA; Pascal JM; Neuhaus D
    Mol Cell; 2015 Dec; 60(5):742-754. PubMed ID: 26626479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Sindbis virus non-structural protein 3 with poly(ADP-ribose) polymerase 1 in neuronal cells.
    Park E; Griffin DE
    J Gen Virol; 2009 Sep; 90(Pt 9):2073-80. PubMed ID: 19515826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) polymerases: managing genome stability.
    Meyer-Ficca ML; Meyer RG; Jacobson EL; Jacobson MK
    Int J Biochem Cell Biol; 2005 May; 37(5):920-6. PubMed ID: 15743666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues.
    Johansson M
    Genomics; 1999 May; 57(3):442-5. PubMed ID: 10329013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of anti-peptide antibodies directed towards the automodification domain and apoptotic fragment of poly (ADP-ribose) polymerase.
    Duriez PJ; Desnoyers S; Hoflack JC; Shah GM; Morelle B; Bourassa S; Poirier GG; Talbot B
    Biochim Biophys Acta; 1997 Feb; 1334(1):65-72. PubMed ID: 9042367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.